| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.63▲ | 1.64▼ | 1.64▼ | 1.67▼ | 1.86▼ |
| MA10 | 1.66▼ | 1.66▼ | 1.67▼ | 1.67▼ | 2.02▼ |
| MA20 | 1.67▼ | 1.69▼ | 1.67▼ | 1.87▼ | 2.13▼ |
| MA50 | 1.67▼ | 1.76▼ | 1.82▼ | 2.04▼ | 1.19▲ |
| MA100 | 1.84▼ | 1.93▼ | 1.99▼ | 2.14▼ | 1.02▲ |
| MA200 | 2.02▼ | 2.09▼ | 2.08▼ | 1.32▲ | 1.54▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.002▼ | 0.003▲ | -0.020▼ | -0.138▼ |
| RSI | 42.190▼ | 43.420▼ | 42.736▼ | 32.485▼ | 46.155▼ |
| STOCH | 15.908▼ | 15.783▼ | 21.198 | 19.112▼ | 15.152▼ |
| WILL %R | -84.615▼ | -88.889▼ | -88.889▼ | -90.179▼ | -94.651▼ |
| CCI | -75.779 | -93.079 | -95.368 | -76.987 | -195.876▼ |
|
Thursday, November 06, 2025 01:15 PM
Presented new preclinical data on INB-619, a novel gamma-delta (γδ) T cell engager (TCE), demonstrating equivalent potency comparable to FDA-approved commercial products with minimal adverse cytokine ...
|
|
Wednesday, October 29, 2025 11:05 PM
) has been revised to $50.24 / share. This is a decrease of 22.13% from the prior estimate of $64.52 dated September 27, 2025. The price target is an average of many targets provided by analysts. The ...
|
|
Wednesday, October 29, 2025 05:38 AM
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.59 | 1.70 | 1.59 | 1.59 | 43,283 |
| 13/11/25 | 1.67 | 1.77 | 1.6236 | 1.64 | 60,805 |
| 12/11/25 | 1.67 | 1.70 | 1.64 | 1.70 | 27,982 |
| 11/11/25 | 1.72 | 1.89 | 1.66 | 1.68 | 54,606 |
| 10/11/25 | 1.61 | 1.80 | 1.56 | 1.72 | 84,929 |
| 07/11/25 | 1.68 | 1.75 | 1.5301 | 1.55 | 88,950 |
| 06/11/25 | 1.65 | 1.7297 | 1.64 | 1.66 | 61,909 |
| 05/11/25 | 1.63 | 1.70 | 1.60 | 1.63 | 29,299 |
| 04/11/25 | 1.96 | 2.14 | 1.54 | 1.65 | 276,500 |
| 03/11/25 | 1.95 | 1.95 | 1.82 | 1.88 | 68,500 |
|
|
||||
|
|
||||
|
|